Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02897128 · ClinicalTrials.gov registry record
Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma
A clinical trial of Sarcoma,Soft Tissue, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 39
- Enrollment target
- 4
- Study locations
NCT02897128: Completed study of Sarcoma,Soft Tissue, sponsored by The Cleveland Clinic.
NCT02897128 is a study of Sarcoma,Soft Tissue that has completed, run by The Cleveland Clinic. The registered enrollment target is 39 participants, below the 74-participant average among 12 other Sarcoma,Soft Tissue trials with a reported enrollment target (47% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02897128, a study of Sarcoma,Soft Tissue, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 4
- Study locations
Study Summary
Wound complications after sarcoma resection are frequent and potentially devastating problem. The burden of surgical wound complications in the lower extremity after preoperative external beam radiation therapy (EBRT) for soft tissue sarcoma is estimated at 43%. A noninvasive method of predicting complications would be extremely beneficial. The aim of this study is to evaluate the relationship between preoperative skin oxygenation and wound outcomes in a multi-center prospective analysis. This information could lead to a change in practice regarding surgical timing and adjunctive interventions to improve wound healing outcomes.
Primary Outcome
Your wound will be assessed clinically for evidence of healing or any wound complication (ie. infection, dehiscence, seroma).
Conditions Studied
Interventions
- OTHER Observational Only - Transcutaneous Oxygen Measurement
Study Locations (4)
Florida
- University of Florida - Gainesville
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Ohio
- Cleveland Clinic - Cleveland
Oklahoma
- University of Oklahoma - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2016-07 |
| Est. Completion | 2021-01-15 |
What the finished NCT02897128 record still lists
NCT02897128 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 74-participant average among 12 other Sarcoma,Soft Tissue trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Sarcoma,Soft Tissue appearing as the primary indexed condition, and to 1 intervention - of which Observational Only - Transcutaneous Oxygen Measurement is the first listed.
NCT02897128 reports a single indexed study location in Florida, Iowa, Ohio.
Frequently Asked Questions
What is clinical trial NCT02897128 about?
NCT02897128 is a clinical study titled "Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma". Wound complications after sarcoma resection are frequent and potentially devastating problem. The burden of surgical wound complications in the lower extremity after preoperative external beam radiation therapy (EBRT) for soft tissue sarcoma is estimated at 43%. A noninvasive method of predicting co...
What is the current status of trial NCT02897128?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2016-07. Estimated completion is 2021-01-15.
What conditions does trial NCT02897128 study?
This clinical trial studies the following conditions: Sarcoma,Soft Tissue.
What interventions are being tested in trial NCT02897128?
The interventions under investigation include: Observational Only - Transcutaneous Oxygen Measurement (OTHER).
Who is sponsoring clinical trial NCT02897128?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02897128 being conducted?
This trial has 4 study locations across Florida, Iowa, Ohio, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma,Soft Tissue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02897128's enrollment target sits among peer trials
39 7th of 12 higher than 6 of 12 other Sarcoma,Soft Tissue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma,Soft Tissue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
RECRUITING · Phase 2
-
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
RECRUITING · Phase 1
-
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma
ACTIVE NOT RECRUITING · Phase 1
-
A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
ACTIVE NOT RECRUITING · Phase 2
-
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia